Custom Spine Receives 510k Clearance Of Regent ACP
Regent ACP, Custom Spine’s anterior cervical plate system, has received 510k Clearance from the U.S. Food and Drug Administration (FDA). This product clearance marks the latest addition to Custom Spine’s continually expanding product line. Regent ACP is a low profile anterior cervical plate system that was designed with innovative self-locking slides to give the surgeon confidence of the plate being securely locked into place.
source : www.medicalnewstoday.com
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Related News:
- Abbott Receives U.S. FDA Approval For New Cataract Multifocal Intraocular Lens
- Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment
- OrthoDynamix LLC Receives FDA 510(k) Clearance For ArthroSteer(R) 3.5mm Ablator
- Sunridge Receives Approval For Its Non-Invasive Glaucoma Treatment In China
- Paloma Pharmaceuticals Receives Approval To Enter Phase I Clinical Trials
- Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)
- Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men
- Teva Receives Favorable Court Decision Regarding Generic Temodar(R)
- Glaucoma Research: IU Optometry’s Swanson Receives $2.35 Million From NIH
- Amgen Receives CHMP Positive Opinion For Prolia(TM) (Denosumab) In The European Union
Details :
Submited at Friday, November 6th, 2009 at 1:01 pm on Orthopaedic by Alina
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















